Irvine, CA -- (October 1, 2012) – WALTHAM, Mass. – CounterTack, the industry's first and only provider of in-progress cyber attack intelligence and response solutions, today announced it has named Stuart McClure, president and CEO of Cylance and former McAfee global chief technology officer, to its Board of Directors. CounterTack provides unprecedented levels of intelligence in attacks currently taking place inside the network perimeter.
"CounterTack is taking a truly unique approach to solving today's most challenging security problem: advanced, highly targeted attacks that have already infiltrated enterprise networks." said McClure. "I look forward to working alongside some of the industry's most innovative security leaders to further accelerate the company's rapid growth, while bringing to market unprecedented levels of intelligence and visibility into in-progress cyber attacks."
An acclaimed security visionary, McClure has more than 22 years of technology and executive leadership experience with profound technical, operational and financial expertise. Currently, McClure is the president and CEO of stealth security firm Cylance, Inc. McClure most recently served as global chief technology officer at McAfee. Previously, he held positions as executive director of security services for Kaiser Permanente, served as senior vice president of global threats and research at McAfee Labs where he led an elite global security threats team, and was founder, president and chief technology officer of Foundstone (acquired by McAfee in 2004). Widely recognized for his extensive and in-depth knowledge of security, McClure is one of the industry's leading authorities in information security. His first book, Hacking Exposed: Network Security Secrets & Solutions has been translated into more than 30 languages and is the definitive best-selling computer security book.
"Stuart's deep knowledge of the security industry and seasoned expertise make him a powerful addition to our Board of Directors," said Neal Creighton, chief executive officer at CounterTack. "His strategic guidance will be invaluable as CounterTack continues to build strong momentum, sparking the revolution the security industry so desperately needs."
In addition to McClure, the members of CounterTack's Board of Directors are Retired Admiral William J. Fallon, chairman; Neal Creighton, chief executive officer; Alen Capalik, founder and chief architect; Mark Hatfield, partner at Fairhaven Capital; Christopher Boies, partner at Boies, Schiller & Flexner LLP; and Alex Doll, CEO of OneID.
CounterTack, the industry's first and only in-progress attack intelligence and response solution provider, was born out of the critical need for enterprise and government organizations to approach security in a completely different way – combating advanced persistent threats with a new line of defense. Each year, more than $32 billion is spent worldwide on security technologies, yet motivated cyber attackers are still finding ways to penetrate the most sophisticated, layered defenses. CounterTack solves this problem by offering the fastest detection and deepest attack intelligence available, enabling customers to actively engage with the attacker and take control over the impact of the attack – even while it's happening.
Based in Waltham, Mass., CounterTack is backed by Fairhaven Capital and a group of private investors.
About Cylance® Inc.
Cylance is the only company to offer a preventive cybersecurity solution that stops advanced threats and malware at the most vulnerable point: the endpoint. Applying a revolutionary artificial intelligence approach, the Cylance endpoint security solution, CylancePROTECT®, analyzes the DNA of code prior to its execution on the endpoint to find and prevent threats others can’t, while using a fraction of the system resources associated with endpoint antivirus and detect and respond solutions that are deployed in enterprises today. For more information visit: www.cylance.com
Cylance and CylancePROTECT are registered trademarks or trademarks owned by Cylance Inc. in the United States and other jurisdictions and may not be used without prior written permission. All other trademarks are the property of their respective owners.